Short Interest in SQI Diagnostics Inc. (OTCMKTS:SQIDF) Decreases By 88.5%

SQI Diagnostics Inc. (OTCMKTS:SQIDF) saw a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 4,000 shares, a decline of 88.5% from the September 15th total of 34,800 shares. Based on an average daily volume of 11,600 shares, the short-interest ratio is presently 0.3 days.

Shares of OTCMKTS:SQIDF remained flat at $$0.15 during midday trading on Thursday. The firm’s 50-day moving average is $0.14 and its 200-day moving average is $0.18. SQI Diagnostics has a 1 year low of $0.11 and a 1 year high of $0.44.

About SQI Diagnostics

SQI Diagnostics, Inc is a life sciences and diagnostics company. It develops multiplexed tests and automated systems for customers who need to measure a variety of biomarkers in blood or other common sample types and commercialize proprietary technologies and products for microarray diagnostics. The firm offers solutions to pharmaceutical and biotechnology drug development, human diagnostic testing and animal health diagnostic tests.

Featured Story: Example of operating income, EBIT and EBITDA

Receive News & Ratings for SQI Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SQI Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.